Oh, what a joyous day for the world of medicine! We’ve stumbled upon a groundbreaking revelation that when you can’t slice and dice your way through metastatic epidural spinal cord compression (MESCC) from those pesky solid tumors, zapping it with stereotactic body radiation therapy (SBRT) might just be the next best thing. Who would’ve thought, right?

So, here’s the scoop from the archives of a single institution’s heroic efforts between 2009 and 2020: They took a nostalgic trip down memory lane, looking back at patients with Bilsky grade 2 to 3 MESCC who were treated with SBRT. And, because they’re thorough like that, they even included the poor souls who had surgery but still scored a solid ≥2 on the Bilsky scale of “Yikes, that’s still pretty bad.”

These meticulous researchers checked up on their patients every 3 to 4 months post-SBRT, like clockwork, assessing everything from neurologic exams to how much their backs hurt. And, drumroll please… the local recurrence rates were a mere 5.1%, 7.5%, and 14.1% at 6, 12, and 24 months, respectively. Not too shabby, considering the alternative is, well, not great.

But wait, there’s more! Some patients even had the audacity to improve after SBRT. A whopping 16.2% of initial Bilsky grade 2 patients had the nerve to get better, and 38.4% of the grade 3 patients also decided to join the party. As for pain, a good chunk of patients reported complete or partial responses at 3 and 6 months post-SBRT. And, because walking is generally considered a good thing, 17.8% and 25.0% of patients were strutting better at 3 and 6 months, respectively.

In conclusion, the researchers proudly present the largest series to date of high-grade MESCC patients treated with SBRT, patting themselves on the back for suggesting that SBRT is a “reasonable approach” for those who can’t go under the knife or didn’t quite make the cut (pun intended). So, let’s all raise our radiation shields in salute to SBRT, the unsung hero for inoperable MESCC patients!